Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

News

  • 1
    News

    Real-world data show SGLT2 inhibitors for diabetes triple DKA risk

    July 29, 2020

    The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.

  • 1
    News

    MIS-C is a serious immune-mediated response to COVID-19 infection

    July 28, 2020

    Multisystem inflammatory syndrome in children (MIS-C) is still a moving target because there is much still to learn about it.

  • News

    NFL’s only physician player opts out of 2020 season over COVID

    July 28, 2020

    “I cannot allow myself to potentially transmit the virus in our communities simply to play the sport that I love. If I am to take risks, I will do it caring for patients.”

  • News

    Diary of a rheumatologist who briefly became a COVID hospitalist

    July 28, 2020

    As a rheumatologist, it had been well over 10 years since I had last done any inpatient work. I was filled with trepidation, but I was also excited to dive in.

  • News

    US News releases latest top hospitals list, adds COVID heroes

    July 28, 2020

    Our Hospital Heroes series is a tribute to recognizing individuals at urban and rural hospitals in communities across the country.

  • 1
    News

    Hospitalist movers and shakers – July 2020

    July 27, 2020

    Take note of some recent career transitions in the hospital medicine community.

  • 1
    News

    COVID-19 fears would keep most Hispanics with stroke, MI symptoms home

    July 27, 2020

    Survey: Hispanics are significantly more likely than Blacks or Whites to be afraid to go to the hospital for a heart attack or stroke.

  • 1
    News

    Cleaner data confirm severe COVID-19 link to diabetes, hypertension

    July 27, 2020

    Initial reports that tied more severe COVID-19 disease to diabetes or hypertension used confounded data, but more refined data show similar links.

  • 1
    News

    Ultrasound, cardiac CT valuable in COVID-19 assessment

    July 27, 2020

    An expert panel of the American College of Cardiology offers evidence-based guidance for evaluating cardiac complications of COVID-19 infections.

  • 1
    News

    Combination therapy quells COVID-19 cytokine storm

    July 27, 2020

    “While not a randomized clinical trial, and thus susceptible to unmeasured bias, the study adds to mounting evidence that supports targeting the excessive inflammation found in some patients with COVID-19.”

Previous1 … 120 121 122 123 124 … 798Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences